drugset / Trial / NCT02056236

Summary

The purpose of this study is to estimate the effect of medical treatment of electro-encephalographic status epilepticus on neurological outcome of patients with postanoxic encephalopathy after cardiac arrest.

Timeline

Start
2014-04
Primary completion
2021-04-24
Completion
2022-01-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 1000 mg Intravenous
Subject Lorazepam Small molecule
Subject Midazolam Small molecule
Subject Phenytoin Unknown 150 mg Intravenous
Subject Propofol Small molecule 8 mg/kg
Subject Thiopental Small molecule 5 mg/kg
Subject Valproic Acid Small molecule 15 mg/kg Intravenous

Indications